Calcium D-Glucarate for Liver Health

Verdict: Unverified: plausible mechanism, no human liver evidence

There are no human trials showing that calcium D-glucarate improves any measure of liver health, so its popular "liver detox" positioning rests on mechanism and animal data rather than proven clinical benefit. The evidence is graded Unverified, not effective.

U ⚫ U Unverified Taiwan Regulatory Restriction

🔬Why this grade7-layer evidence engine

The grade is Unverified because not a single human trial has tested calcium D-glucarate against a real liver outcome such as ALT/AST, liver fat, NAFLD or fibrosis. The supporting literature is thin and old: 1990s rat studies showing the compound inhibits beta-glucuronidase by roughly 37-70% in serum and liver tissue (PMID 2346674) and a rat pharmacokinetic study establishing how it is absorbed and converted to the active metabolite (PMID 9101079). Narrative reviews (PMID 12197785, PMID 7744577) only restate this rationale and explicitly note that human outcome data are very limited.

The one recent paper invoking liver detoxification (PMID 36771439, 2023) is not an experiment at all but an industry-funded computer simulation by authors affiliated with Applied Food Sciences and CytoSolve. The engine flags this conflict of interest, and a modeled dose-response cannot substitute for clinical results. Mechanistic plausibility is real, but its translation into measurable human liver benefit has never been validated.

Authorities reinforce the caution. Examine.com has no entry, NIH/MSKCC notes the compound has not been shown to treat or prevent disease in humans, and Mayo Clinic warns that liver "detox" supplements are usually a bad idea and can even cause harm. Only Health Canada grants a limited structure-function claim that it "helps support glucuronidation," which is a marketing-tier statement, not proof of clinical efficacy; the FDA, EFSA and others grant no such claim. A drug-interaction flag also applies, since accelerating glucuronidation may lower levels of medications cleared by that pathway.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.42
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Taiwan Regulatory Restriction
Confidence
77%
Broadly consistent
Evidence level
E7
Single small RCT

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.20
L2 PubMedPrimary literature
0.40
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L5 Clinical bodiesAuthoritative stance
0.51
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.42
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — | C→U 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 1 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Mechanistic Understanding of D-Glucaric Acid to Support Liver Detoxification Essential to Muscle Health Using a Computational Systems Biology Approach
PMID: 36771439 2023 Other n = 0
Finding: In silico modelling predicted GA reduces hepatocyte ROS (70 nM to 16 nM at 1.8 mg), glucuronide deconjugates (4.9e-3 to 1.7e-5 nM at 26 mg), beta-glucuronidase (4.75 to 1.19 nM at 26 mg) and modestly downregulates apoptosis; no human or animal outcome data.
🟠 Limited quality ⚠️ Industry-funded Effect size: Computational dose-response only; no clinical or in vivo effect size
View on PubMed
Effect of calcium glucarate on beta-glucuronidase activity and glucarate content of certain vegetables and fruits
PMID: 2346674 1990 Animal Study
Finding: Single oral dose suppressed beta-glucuronidase by 57% in serum, 44% in liver microsomes, 37% in lung and 39% in intestine; chronic feeding reduced small-intestine bacterial flora activity by 70% and colon flora by 54%.
🟠 Limited quality Government Effect size: 37-70% beta-glucuronidase inhibition (tissue-dependent)
View on PubMed
Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention
PMID: 9101079 1997 Animal Study
Finding: Glucarate salt converts in the stomach to D-glucaro-1,4-lactone, the active beta-glucuronidase inhibitor, is absorbed and distributed systemically, then excreted in urine - establishing the pharmacokinetic basis for downstream glucuronidation-support claims.
🟠 Limited quality Government Effect size: Pharmacokinetic only; no clinical efficacy endpoint
View on PubMed
Calcium-D-glucarate (Altern Med Rev monograph)
PMID: 12197785 2002 Other
Finding: Review concludes oral calcium-D-glucarate inhibits beta-glucuronidase and may support phase II liver detoxification of estrogens, xenobiotics and carcinogens, but acknowledges human outcome data are very limited; no original liver-endpoint findings.
🟠 Limited quality Effect size: Not applicable (review)
View on PubMed
Calcium glucarate as a chemopreventive agent in breast cancer (Heerdt et al.)
PMID: 7744577 1995 隨機對照試驗
Finding: Authors propose calcium glucarate can modify hormonal milieu and detoxify environmental carcinogens via glucuronidation, and call for clinical trials; no liver-outcome data and no completed human efficacy results reported.
🟠 Limited quality Effect size: Not reported
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Neutral
CALCIUM SACCHARATE [USP MONOGRAPH]; CALCIUM SACCHARATE [USP-RS]; UNII 6AP9J91K4V; CAS 5793-89-5; Molecular Formula C6H8O8.Ca.4H2O; synonyms include Calcium D-Glucarate (1:1), Tetrahydrate; Calcium D-Saccharate Tetrahydrate; D-Glucaric Acid Calcium Salt Tetrahydrate. UNII availability does not imply any regulatory review or approval. source↗
L4e WHO
Supportive
Product Name: Calcium D-Glucarate. NPN: 80083170. Licence Holder: New Roots Herbal Inc. Medicinal Ingredient: D-Glucaric acid calcium salt (1:1), 650.0 mg. Recommended Use or Purpose: Helps to support glucuronidation, a liver detoxification pathway. Recommended Dose: Adults take 2 capsules daily. Cautions and Warnings: Do not use if you are pregnant or breastfeeding. Consult a health care pract… source↗
L5a NIH Office of Dietary Supplements
Cautious
Although lab studies suggest anticancer effects, calcium glucarate has not been shown to treat or prevent cancer in humans. source↗
L5e Specialty Society (condition-mapped)
Neutral
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-liver-health-INT-calcium-d-glucarate-001 繁體中文版 →